We are live on ! Find out more
AP

AtonRa Partners Portfolio holdings

AUM $50.2M
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
10 Year Est. Return
AUM
$64.6M
AUM Growth
-$3.91M
Cap. Flow
-$8.9M
Cap. Flow %
-13.78%
Top 10 Hldgs %
18.76%
Holding
126
New
4
Increased
10
Reduced
102
Closed
10

Top Buys

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$554K
2
PEGA icon
Pegasystems
PEGA
+$496K
3
FLYW icon
Flywire
FLYW
+$455K
4
MELI icon
Mercado Libre
MELI
+$366K
5
FSLR icon
First Solar
FSLR
+$66K

Sector Composition

Rank Sector Weight
1 Technology 48.21%
2 Healthcare 37.8%
3 Industrials 6.21%
4 Financials 5.54%
5 Communication Services 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVH icon
51
Evolent Health
EVH
$475M
$519K 0.8%
+17,124
New +$554K
LNTH icon
52
Lantheus
LNTH
$6.82B
$514K 0.8%
6,123
-883
-13% -$79.2K
ZS icon
53
Zscaler
ZS
$23B
$513K 0.79%
3,504
-343
-9% -$41.9K
SNOW icon
54
Snowflake
SNOW
$92.9B
$512K 0.79%
2,907
-644
-18% -$105K
MSTR icon
55
Strategy Inc
MSTR
$33.5B
$508K 0.79%
14,830
-2,260
-13% -$68.5K
KYMR icon
56
Kymera Therapeutics
KYMR
$9.1B
$505K 0.78%
21,947
-1,832
-8% -$52.5K
JKHY icon
57
Jack Henry & Associates
JKHY
$10.7B
$504K 0.78%
3,011
-370
-11% -$57.6K
OM icon
58
Outset Medical
OM
$74.9M
$502K 0.78%
1,530
-263
-15% -$80.2K
ITCI
59
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$495K 0.77%
7,823
-724
-8% -$45.1K
PATH icon
60
UiPath
PATH
$5.62B
$495K 0.77%
29,857
-15,986
-35% -$256K
CFLT
61
DELISTED
Confluent
CFLT
$486K 0.75%
13,757
-9,698
-41% -$271K
XYL icon
62
Xylem
XYL
$28.5B
$484K 0.75%
4,298
+326
+8% +$34.5K
IONS icon
63
Ionis Pharmaceuticals
IONS
$9.35B
$477K 0.74%
11,636
-708
-6% -$27.2K
TDY icon
64
Teledyne Technologies
TDY
$30.4B
$476K 0.74%
1,159
-105
-8% -$43.3K
NCNO icon
65
nCino
NCNO
$1.81B
$475K 0.73%
15,756
-2,087
-12% -$53.1K
VEEV icon
66
Veeva Systems
VEEV
$30.3B
$474K 0.73%
2,398
-146
-6% -$26.6K
FLYW icon
67
Flywire
FLYW
$1.96B
$471K 0.73%
+15,164
New +$455K
CPAY icon
68
Corpay
CPAY
$24.2B
$463K 0.72%
1,843
-34
-2% -$7.75K
AXNX
69
DELISTED
Axonics, Inc. Common Stock
AXNX
$461K 0.71%
9,134
-1,510
-14% -$80.3K
PL icon
70
Planet Labs
PL
$7.3B
$459K 0.71%
142,584
-13,110
-8% -$52K
ENV
71
DELISTED
ENVESTNET, INC.
ENV
$452K 0.7%
7,623
-961
-11% -$55.7K
ENPH icon
72
Enphase Energy
ENPH
$4.84B
$448K 0.69%
2,675
+197
+8% +$35.2K
NTLA icon
73
Intellia Therapeutics
NTLA
$1.5B
$415K 0.64%
10,174
-713
-7% -$28.9K
FTNT icon
74
Fortinet
FTNT
$112B
$414K 0.64%
5,473
-501
-8% -$34.1K
ACIW icon
75
ACI Worldwide
ACIW
$5.72B
$410K 0.63%
17,677
-210
-1% -$5.08K

Similar funds

AtonRa Partners's Q2 2023 Portfolio in Review

As of Q2 2023, AtonRa Partners held 126 positions worth $64.6M, down 5.7% from $68.5M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

AtonRa Partners withdrew a net $8.9M in Q2 2023, closing 10 positions and reducing 102 holdings. Its most notable exit was CATALENT, INC., an estimated $529K position sold in full.

By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 48% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AtonRa Partners opened a new position in Evolent Health worth $519K.

  • AtonRa Partners's largest Q2 2023 buy was Evolent Health: 17,124 shares worth $519K.
  • AtonRa Partners added most to First Solar in Q2 2023, an estimated $66K increase.
  • AtonRa Partners's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $584K.
  • AtonRa Partners fully exited CATALENT, INC. in Q2 2023, selling an estimated $529K.
  • AtonRa Partners's ten largest holdings make up 19% of its $64.6M portfolio in Q2 2023.
  • AtonRa Partners opened 4 new positions and closed 10 in Q2 2023.
  • AtonRa Partners's portfolio value fell 5.7% quarter-over-quarter to $64.6M.

Based on AtonRa Partners's 13F filing for Q2 2023, filed 18 Jul 2023.